Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3111-3120 Newer>

The Motley Fool September 11, 2006 Brian Lawler	Barr's Bidding War Barr Pharmaceuticals takes a big bite of the booming generics market. Investors, take note.
The Motley Fool September 8, 2006 Brian Lawler	Ligand's Drug Sale For the pharmaceutical's marketed drugs, everything must go. Investors, take note.
The Motley Fool September 8, 2006 Ralph Casale	Genta's Down, but Is It Out? An FDA advisory committee voted not to recommend Genta's lead drug, Genasense, for approval. The news has knocked Genta's stock down by nearly two-thirds over the past week.
Pharmaceutical Executive September 1, 2006 Bill Trombetta	Industry Audit This fifth annual report dives deep into the numbers and comes up with the pharmaceutical industry's true top performers.
Pharmaceutical Executive September 1, 2006 Beth Herskovits	Freedom of Information IMS and Verispan sue New Hampshire to buy prescriber data and to protect the data sellers' free-speech rights.
Pharmaceutical Executive September 1, 2006 Mark Bard	Public Access The universe of online consumers is growing slower than ever. But more patients and physicians are using the Web to search for information about health and medicine.
Pharmaceutical Executive September 1, 2006	Sewing Up New Sales Simple, elegant lines are the backbone of any good design, including a new sales model. Get that right, and your model can be tailored to fit any customer.
Pharmaceutical Executive September 1, 2006 Kieran Hartsough	Benchmarking AIDS Pharma is taking on the global AIDS crisis. But who has crafted the best approach? The Interfaith Center on Corporate Responsibility defines best practices and matches major companies head-to-head. Grades are posted inside.
Pharmaceutical Executive September 1, 2006 Jill Wechsler	Washington Report: New Partnerships Pursue Old Diseases A new wave of collaborations between industry, non-profits, and government seeks affordable treatments for neglected diseases around the world.
Pharmaceutical Executive September 1, 2006 Patrick Clinton	From the Editor: Undecided People are buying drugs, because companies are selling drugs. Interfere with the selling process, and people won't buy as many drugs.
<Older 3111-3120 Newer> Return to current articles.